Metabasis hangs on with new round of job cuts
This article was originally published in Scrip
Executive Summary
Metabasis Therapeutics will cut 85% of its workforce as the firm continues its second restructuring this year. By cutting all but seven employees, the firm has also raised the prospect of closing its operations.